The central amygdala (CeA) is involved in the processing of anxiety and stress and plays a role in ethanol consumption. Chronic ethanol recruits stress systems in the CeA, leading to aversive withdrawal symptoms. Although primarily GABAergic, CeA contains glutamatergic afferents, and we have reported inhibitory effects of ethanol on locally evoked glutamatergic responses in CeA of Wistar and Marchigian Sardinian alcohol-preferring (msP) rats. Notably, msP rats display enhanced anxiety, stress and alcohol drinking, simulating the alcohol-dependent phenotype. Endocannabinoids are also involved in regulation of stress, and we previously demonstrated that cannabinoid receptor type 1 (CB 1 ) activation decreases CeA GABAergic signaling and blocks ethanol enhancement of GABAergic signaling. Here, we sought to investigate the effects of CB 1 activation (WIN 55,212-2; Win) and antagonism (AM251) with and without acute ethanol on glutamatergic synapses in CeA of female and male Wistar and msP rats. Using intracellular sharp pipette electrophysiology, we examined the effects of CB 1 compounds on locally evoked excitatory postsynaptic potentials (EPSPs) in CeA and compared effects between strains, gender and estrous cycle. Acute ethanol decreased EPSP amplitudes in Wistars, and in male but not female msPs. Win decreased EPSP amplitudes in msPs, and in male but not female Wistars. Combined application of Win and ethanol resulted in strain-specific effects in female rats. We found no tonic CB 1 signaling at glutamatergic synapses in CeA of any groups, and no interaction with ethanol.
INTRODUCTION
The central amygdala (CeA) is a brain region involved in the processing of emotional stimuli and behaviors related to anxiety and stress (Koob & Le Moal 2008) . The CeA serves as the major output of the amygdala, receiving innervation from other amygdala nuclei, prefrontal cortex, hypothalamus and many other brain regions, as well as local intra-amygdalar connections. The CeA also plays an important role in alcohol addiction, as disruptions in CeA stress system functioning can drive alcohol consumption (Koob & Volkow 2010) . Although & Weiner 2017). Interestingly, women are more likely to develop stress/anxiety-related disorders, including PTSD (Olff et al. 2007; McLean et al. 2011; Gilpin & Weiner 2017) , while men are more likely to develop AUD (Erol & Karpyak 2015; Gilpin & Weiner 2017) . However, in patients with co-morbid PTSD and AUD, women are more likely to have PTSD precede development of AUD (Sonne et al. 2003) . These studies highlight the complex interactions between gender, stress disorders and alcoholism. In fact, alcoholism can be considered a stress-related disorder as stress systems are disrupted in the transition from casual alcohol use to alcohol dependence (Koob 2013; Seo & Sinha 2014; Galesi et al. 2016) . Once in this dependent state, hypersensitive stress systems cause negative affective withdrawal symptoms, which drives further drinking to alleviate these symptoms (Koob 2013) . Creating genetic rodent models of these behavioral phenotypes allows study of important systems of interest. In this capacity, the Marchigian Sardinian alcohol-preferring (msP) rat strain (Ciccocioppo et al. 2006) displays elevated stress and anxiety responses as well as excessive ethanol intake that mimics changes observed in ethanol-dependent rats (Ayanwuyi et al. 2013; Cippitelli et al. 2015) , highlighting the use of the msP as a genetic model of alcohol dependence.
Many neuropeptides and neuromodulators can affect stress and anxiety-related signaling in the CeA. The endogenous cannabinoids [endocannabinoids (eCBs)] are bioactive lipids that have been implicated in regulatory control of stress signaling in the brain (Riebe & Wotjak 2011; Ruehle et al. 2012) . Additionally, eCB signaling in response to stress occurs in a sex-specific manner in some brain regions (Shonesy et al. 2014; Tabatadze et al. 2015; Silva et al. 2016; Zer-Aviv & Akirav 2016) . The two most prevalent eCBs are N-arachidonoyl ethanolamine (anandamide) and 2-arachidonoylglycerol, and these eCBs are synthesized as needed, or 'on demand', to act in a retrograde fashion on presynaptic terminals inhibiting neurotransmitter release. The cannabinoid receptor type 1 (CB 1 ) is a G-protein-coupled receptor and is the primary neuronal eCB receptor in the brain, and CB 1 activation modulates glutamatergic transmission by decreasing glutamate release (Gerdeman & Lovinger 2001; Ramikie et al. 2014) .
The CB 1 system is also sensitive to the effects of alcohol exposure and withdrawal (Alvarez-Jaimes, Stouffer, & Parsons 2009; Serrano & Parsons 2011; Serrano et al. 2012) . We have previously characterized CB 1 involvement in the effects of acute ethanol on stimulated CeA GABAergic signaling (Roberto et al. 2010) . Using an in vitro slice preparation, we sought to determine the CB 1 involvement in stimulated CeA glutamatergic signaling in both male and female msP and Wistar (the background strain of msP) rats, using the agonist Win 55,212-2 (Win) and the antagonist AM251, and any possible interactions with acute ethanol application.
MATERIALS AND METHODS

Animals
This study used 15 male and 35 female msP rats and 21 male and 12 female Wistar rats. Average weights were 269.4 ± 11.4 g for male rats and 141.7 ± 5.7 g for female rats. Wistar rats were obtained from Charles River (Raleigh, NC, USA); a colony of msP rats is maintained at The Scripps Research Institute and was originally obtained from the School of Pharmacy at the University of Camerino (Italy). For all female rats, estrous cycle was not selected for and was determined via vaginal cytology from smears obtained under anesthesia the day of recording, to avoid stress axis activation in msP rats. Rats were determined to be within one of three estrous cycle groups: proestrus, estrus or diestrus (metestrus and diestrus). Additionally, one randomization control group for estrous cycle of female msPs was utilized for some experiments; these rats did not have vaginal cytology determined. All rats were housed in a temperature-controlled and humidity-controlled room on a 12-hour light/dark cycle (lights off at 1 PM) with food and water available ad libitum. All procedures, care and msP colony breeding were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were reviewed and approved by the Institutional Animal Care and Use Committee of The Scripps Research Institute.
Electrophysiology
We prepared slices from rats anesthetized with isoflurane (3-5 percent) followed by rapid decapitation and removal of the brain immediately into an ice-cold high-sucrose cutting solution (sucrose 206 mM; KCl 2.5 mM; CaCl 2 0.5 mM; MgCl 2 7 mM; NaH 2 PO 4 1.2 mM; NaHCO 3 26 mM; glucose 5 mM; HEPES 5 mM; pH 7.4). Coronal slices of 400 μm thick were cut on a Leica 1200S vibratome (Buffalo Grove, IL, USA), incubated in an interface configuration for 17 minutes and then completely submerged and continuously superfused (flow rate of 2-4 ml/min) with 95 percent O 2 /5 percent CO 2 equilibrated room temperature artificial cerebrospinal fluid (aCSF) solution (NaCl 130 mM; KCl 3.5 mM; NaH 2 PO 4 1.25 mM; MgSO 4 ·7H 2 O 1.5 mM; CaCl 2 2.0 mM; NaHCO, 24 mM; glucose 10 mM). All recordings were performed between 1 and 8 hours after slice preparation. We blindly advanced sharp micropipettes filled with 3 M KCl into the medial subdivision of the CeA (Sah et al. 2003) and recorded from all cells in currentclamp mode with neurons held near their resting membrane potential. Data were acquired with an Axoclamp 2B amplifier (Axon Instruments, Foster City, CA, USA) and stored for later analysis using PCLAMP software (Molecular Devices, Sunnyvale, CA, USA). We evoked pharmacologically isolated compound (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) + N-methyl-D-aspartate receptor (NMDAR) mediated) glutamatergic excitatory postsynaptic potentials (EPSPs) by stimulating locally within the CeA through a bipolar stimulating electrode and superfusing the slice with aCSF containing the GABA receptor blockers bicuculline (30 μM) and CGP 55845A (1 μM).
In order to determine the synaptic response parameters for each cell, we performed an input-output (I/O) protocol consisting of a range of five current stimulations, starting at the threshold current required to elicit an EPSP, up to the strength required to elicit the maximum amplitude. These stimulus strengths were maintained throughout the duration of the experiment. We examined paired pulse ratio (PPR), whereby two stimuli of the same intensity are applied at interstimulus intervals of 50, 100 and 200 milliseconds (Manabe et al. 1993; Andreasen & Hablitz 1994; Logrip, Oleata, & Roberto 2016) . PPR is calculated as the amplitude of the second EPSP over that of the first EPSP. The stimulus strength was adjusted such that the amplitude of the first EPSP was~50 percent of the maximal amplitude determined by the I/O protocol. A drug-induced change in PPR reflects presynaptic effects such that an increase in PPR suggests a decrease in neurotransmitter (glutamate) release. All measures were performed prior to (baseline) and during drug application.
Drugs
We purchased CGP 55845A and bicuculline from Sigma (St. Louis, MO, USA). Ethanol (EtOH) was purchased from Remet (La Mirada, CA, USA). WIN 55,212-2 mesylate (Win;
were purchased from Tocris (Ellisville, MO, USA). Bicuculline, Win and AM251 were first dissolved in dimethyl sulfoxide before being added to aCSF superfusate (final concentration of 0.05-0.1 percent dimethyl sulfoxide). Win and AM251 were applied only once per CeA slice. Drugs were added to the aCSF from stock solutions to obtain known concentrations in the superfusate.
Data analysis and statistics
Data were analyzed with Clampfit 10 (Molecular Devices), and GRAPHPAD Prism 5.0 software (GraphPad Software, La Jolla, CA, USA) was used for all statistical analyses. Sex differences were analyzed in two ways: first, all male and all female rats of each strain were compared (M versus F), and then female rats were subdivided into estrous cycle groups (Cycle). Because estrous cycle was not selected for, not all groups are represented in each experiment. M versus F analyses include all cells, while Cycle analyses only include groups as stated. EPSPs were analyzed with t-test for individual comparisons or ANOVA for sex and strain comparisons with a Bonferroni post hoc test for individual differences as appropriate. In all cases, P < 0.05 was the criterion for statistical significance. Data are presented as mean ± SEM, and n refers to the number of cells. Between one and five cells were recorded per animal, and each drug and gender condition (not estrous cycle groups) contain data from at least three animals.
RESULTS
Baseline sex and strain differences in evoked glutamatergic signaling
We recorded locally evoked compound (AMPAR + NMDAR) glutamatergic EPSPs in medial CeA neurons from both female and male Wistar and msP rats to investigate general strain and sex differences. Average neuronal membrane resistance was 146.8 ± 7.5 and 168.3 ± 8.4 MΩ for male and female Wistar rats, respectively, and 146.1 ± 9.7 and 146.4 ± 6.9 MΩ for male and female msP rats, respectively. Resting membrane potential was À76.6 ± 0.9, À80.5 ± 1.2, À78.8 ± 1.1 and À79.5 ± 0.7 mV for male and female Wistar rats and male and female msP rats, respectively. Neither Wistars [F(1, 69) = 0.10, n = 37 cells from 21 male rats and n = 34 cells from 12 female rats] nor msPs [F(1, 81) = 0.93, n = 23 cells from 15 male rats and n = 60 cells from 35 female rats] displayed sex differences in baseline I/O curves (Fig. 1) . Figure 1a shows superimposed EPSP example traces from the five normalized stimulation intensities for both male and female Wistars and msPs. Figure 1b (left panel) shows mean EPSP amplitudes for the five normalized stimulus intensities for neurons from both male and female Wistar rats, with no differences between female and male rats. Figure 1b (Fig. 1c) . We performed further analyses to investigate whether female rats had different baselines based on estrous cycle that were masked by averaging all female rats together; thus we also compared CeA EPSP amplitudes from male rats to subdivided groups from the female rats based on estrous cycle. We did not reliably find animals in proestrus, and although we recorded from a couple msP rats in proestrus (none from female Wistar rats), we did not obtain enough cells in most drug conditions to warrant inclusion of the proestrus data here. Therefore, here ( Fig. 1d) , as in most cases, we examined only diestrus (7.3 ± 0.6 for n = 20 cells from seven Wistars, and 9.1 ± 0.6 mV for n = 32 cells from 20 msPs) and estrus (9.4 ± 0.8 for n = 14 cells from five Wistars, and 8.8 ± 1.0 mV for n = 16 cells from eight msPs). A twoway ANOVA indicated no significant main effect of cycle [F(2, 136 Figure 1e shows representative recordings of paired locally evoked CeA glutamatergic EPSPs from a diestrus female msP rat at an interstimulus interval of 50 milliseconds and an estrus female Wistar rat at interstimulus intervals of 50, 100 and 200 milliseconds. PPR for each strain and cycle for the three interstimulus intervals can be seen in Fig. 1f . By two-way ANOVA, a significant effect of strain was found at the 50-millisecond interstimulus interval [F(1, 127) = 7.085, P < 0.01], with msPs (1.5 ± 0.1 male and 1.4 ± 0.1 female rats) generally having a higher PPR than Wistars (1.2 ± 0.4 male and 1.2 ± 0.1 female rats). However, no main effect of sex [F(1, 127) = 0.004] and no interaction effect [F(1, 127) = 0.05] were found at the 50-millisecond interstimulus interval. At interstimulus intervals of 100 milliseconds (1.3 ± 0.04 and 1.3 ± 0.1 male and female Wistar rats, 1.3 ± 0.1 and 1.4 ± 0.04 male and female msP rats, respectively) and 200 milliseconds (1.1 ± 0.04 and 1.1 ± 0.1 males and female Wistar rats, 1.2 ± 0.1 and 1.1 ± 0.04 male and female msP rats, respectively), there was no main effect of strain [100 Acute ethanol does not decrease evoked glutamatergic signaling in female msP rats
We next investigated the effects of acutely applied 44 mM ethanol (Roberto et al. 2004b) in CeA of female Wistar and msP rats and recapitulated a decrease in evoked CeA EPSP amplitudes in male Wistar and msP rats (Fig. 2) , as we have recently reported (Herman et al. Figure 2a shows the time course of the effect of ethanol on EPSP amplitudes for female Wistar rats, with representative traces from before and after drug application for a diestrus female Wistar (inset). After baseline characterization of each cell (Fig. 1) , application of 44 mM ethanol (10-15 minutes) significantly decreased EPSP amplitudes to 83.7 ± 3.6 percent of baseline (Fig. 2b , at the half-maximal intensity) in male Wistar rats [t(8) = 6.12, P < 0.01, n = 9 cells from seven rats] and to 84.9 ± 3.6 percent of baseline in male msP rats [t(6) = 4.22, P < 0.01, n = 7 cells from six rats]. In female Wistar rats, ethanol also significantly decreased EPSP amplitudes to 78.8 ± 6.7 percent of baseline [t(8) = 3.14, P < 0.05, n = 9 cells from seven rats]. However, in female msP rats, ethanol had no significant effect [t(6) = 1.17, n = 7 cells from five rats] on evoked glutamatergic signaling, with EPSP amplitudes essentially unchanged from baseline (90.9 ± 7.8 percent). We again subdivided female rats by estrous cycle phase for further analysis. In diestrus female Wistar rats (Fig. 2c) , ethanol significantly decreased CeA EPSPs to 84.1 ± 5.2 percent of baseline [t(4) = 3.05, P < 0.05, n = 5 cells from three rats], to a similar extent as male Wistar rats, while estrus Wistars had a large (72.2 ± 14.2 percent) but not significant effect [t(3) = 1.96, n = 4 cells from four rats] of ethanol, decreasing EPSP amplitudes. In diestrus female msP rats (Fig. 2d) , ethanol had no effect [t(4) = 0.20, n = 5 cells from four rats] on EPSPs (101.0 ± 5.2 percent of baseline). We recorded only two cells from estrus msPs, which displayed a non-significant [t(1) = 3.52, n = 2 cells from one rat] decrease (65.5 ± 9.8 percent) upon ethanol application (data not shown). A two-way ANOVA found a significant main effect of cycle [F(2, 26) = 4.95, P < 0.05], but no effect of strain [F(1, 26) = 0.47] and no interaction effect [F(2, 26) = 1.50]. A Bonferroni post hoc revealed a significant difference between diestrus and estrus female rats [t(26) = 3.11, P < 0.05].
Acute ethanol treatment did not significantly change PPR from baseline at interstimulus intervals of 50 milliseconds (128.8 ± 18.3 and 114.8 ± 9.7 percent male and female Wistar rats, 119.3 ± 14.3 and 93.0 ± 14.7 percent male and female msP rats, respectively), 100 milliseconds (105.8 ± 9.1 and 91.4 ± 8.8 percent male and female Wistar rats, 112.9 ± 19.4 and 96.3 ± 6.7 percent male and female msP rats, respectively) or 200 milliseconds (109.2 ± 13.3 and 93.0 ± 9.4 percent male and female Wistar rats, 111.0 ± 17.5 and 119.3 ± 15.3 percent male and female msP rats, respectively) for any of the groups tested (data not shown).
CB 1 agonism does not decrease evoked glutamatergic signaling in female Wistar rats
Because of the aforementioned involvement of amygdalar eCB signaling in stress and anxiety, we next sought to test the effects of CB 1 activation, using the agonist Win, on glutamatergic signaling in the CeA of male and female msP and Wistar rats. After stable baseline characterization of each cell as mentioned earlier, we applied 2 μM Win to the superfusate for 15 minutes. Figure 3a shows representative evoked EPSPs at baseline and during 2 μM Win in neurons from both a male Wistar rat and a diestrus female Wistar rat. The time course of the effect of Win on EPSP amplitudes in female msP rats is shown in Fig. 3b . In male Wistar rats, Win induced a significant yet modest decrease in EPSP amplitudes to 88.5 ± 3.7 percent of baseline [t(11) = 3.14, P < 0.01, n = 12 cells from nine rats], although Win had no effect [t(8) = 0.04, n = 9 cells from five rats] on EPSPs from female Wistar rats (99.6 ± 8.9 percent of baseline). Win caused a significant decrease in EPSPs for both sexes of msPs, with male rats at 81.1 ± 6.7 percent of baseline [t(7) = 2.84, P < 0.05, n = 8 cells from five rats] and female rats at 74.6 ± 3.2 percent of baseline [t(23) = 7.94, P < 0.001, n = 24 cells from 17 rats]. A two-way ANOVA found a significant main effect of strain [F(1, 49) = 9.13, P < 0.01] with msPs having a greater Win effect (Fig. 3c) , but no main effect of sex [F(1, 49) = 0.18] and no interaction effect [F(1, 49) = 2.70]. Figure 3d and e shows the effects of Win on EPSPs when grouped by estrous cycle for Wistars and msPs, respectively. Similar to the grouped female data, compared with baseline, Win had no significant effect on either diestrus (110.4 ± 13.3 percent of baseline) [t(4) = 0.78, n = 5 cells from three rats] or estrus (86.1 ± 8.6 percent of baseline) [t(3) = 1.62, n = 4 cells from three rats] female Wistar rats. Again similar to the grouped female data, Win caused a significant decrease in CeA EPSPs to 77.1 ± 3.5 percent of baseline for diestrus [t(9) = 6.61, P < 0.001, n = 10 cells from nine rats] and 66.5 ± 9.0 percent of baseline for estrus [t(4) = 3.71, P < 0.05, n = 5 cells from three rats] female msP rats. In addition, in a control group of female msP rats that did not have estrous cycle determined, Win significantly decreased [t(8) = 4.00, P < 0.01, n = 9 cells from five rats] EPSP amplitudes to 76.2 ± 5.8 percent of baseline. A two-way ANOVA of strain and cycle (cycle control excluded) again found a significant main effect of strain [F(1, 38) = 12.69, P = 0.001], but no main effect of cycle [F(2, 38) = 2.77] and no interaction effect [F(2, 38) = 2.21].
As with ethanol, Win application did not significantly alter PPR at interstimulus intervals of 50 milliseconds (122.2 ± 9.9 and 113.5 ± 20.6 percent male and female Wistar rats, 110.7 ± 5.9 and 100.5 ± 6.3 percent male and female msP rats, respectively) or 200 milliseconds (108.4 ± 9.8 and 100.7 ± 9.3 percent male and female Wistar rats, 99.3 ± 9.0 and 94.9 ± 4.5 percent male and female msP rats, respectively) for any of the groups tested (data not shown). However, at the 100-millisecond interstimulus interval, Win significantly increased PPR to 127.2 ± 8.7 percent of baseline in male msP rats [t(6) = 3.13, P < 0.05], indicating a presynaptic effect of Win to decrease evoked glutamate release. Win did not significantly alter PPR in Wistars (99.8 ± 9.8 and 113.7 ± 7.2 percent male and female rats, respectively) or female msP rats (98.6 ± 6.5 percent) at the 100-millisecond interstimulus interval (data not shown). 
Win and ethanol interact in a strain-specific manner in female rats
Ethanol has been shown to interact with the eCB system in many different ways, including altering endocannabinoid levels (Alvarez-Jaimes et al. 2009) and altering synaptic transmission (Roberto et al. 2010; Varodayan et al. 2016a; Varodayan et al. 2016b) . Therefore, in a subset (five of 12) of the cells superfused with Win (Fig. 3) , we subsequently co-applied 44 mM EtOH in the continued presence of Win (10-15 minutes) to test possible interaction effects of Win and EtOH (Fig. 4) . In male Wistar rats, this subset of cells retained the modest decreasing effect of Win but is no longer significantly different from baseline [t(4) = 1.22, n = 5 cells from five rats]. In male msP rats, all cells tested with Win received subsequent co-application with ethanol. In both male Wistar and msP rats, the acute ethanolinduced inhibition of glutamate signaling remains in the presence of Win (Fig. 4b) . Ethanol co-applied with Win significantly decreased EPSPs from the effects of Win alone to 64.0 ± 6.7 percent of baseline for Wistars [t(4) = 9.45, P < 0.001] and 53.9 ± 4.0 percent of baseline for msPs [t(7) = 11.60, P < 0.001]. However, in female Wistar rats (Fig. 4a, b) , Win blocks ethanol's effects to where EPSPs in the presence of both drugs were not significantly different [t(7) = 1.44, n = 8 cells from five rats] from baseline at 87.4 ± 8.7 percent of baseline. Interestingly, in female msPs (Fig. 4a, b) , Win induces a significant [t(14) = 4.94, P < 0.001, n = 15 cells from 13 rats] decreasing effect of ethanol on CeA glutamatergic EPSP amplitudes (54.8 ± 4.4 percent of baseline) that was not seen with ethanol alone (Fig. 2) .
When analyzing the female data grouped by estrous cycle, both diestrus (89.1 ± 14.0 percent of baseline) [t(4) = 2.12, n = 5 cells from three rats] and estrus (84.7 ± 7.3 percent of baseline) [t(2) = 0.63, n = 3 cells from two rats] female Wistar rats showed the effect of Win blocking the ethanol-induced decrease in EPSP amplitudes (Fig. 4c) . Notably, in the presence of Win, ethanol induced a significant [t(6) = 3.66, P < 0.05, n = 7 cells from seven rats] reduction in EPSPs in the diestrus (54.5 ± 7.2 percent of baseline) female msP rats (Fig. 4d) . In contrast, in msP estrus female rats, ethanol induced only a modest reduction in the presence of Win, from 66.5 ± 9.0 to 53.3 ± 8.0 percent of baseline [t(4) = 1.88, n = 5 cells from three rats]. The coapplication of ethanol and Win only affected PPR for one group, male Wistar rats at the 200-millisecond interstimulus interval. A one-way repeated measures ANOVA found a significant effect of drug on PPR [F(2, 8) = 5.322, P < 0.05]; however, a Bonferroni post hoc test indicated no significant differences between individual groups (data not shown).
Tonic CB 1 signaling is lacking at CeA-evoked glutamatergic synapses
We previously reported tonic CB 1 signaling at GABAergic synapses in the CeA of male rats susceptible to blockade by the CB 1 -specific antagonist AM251 (Varodayan et al. 2016a; Varodayan et al. 2016b) . Therefore, we applied AM251 (2 μM) to slices for 15 minutes to investigate whether tonic CB 1 signaling occurs at glutamatergic synapses in the CeA of male and female Wistar and msP rats (Fig. 5) . Figure 5a shows the time course of the effects of AM251 on EPSP amplitudes in female msP rats, with representative traces from before and after drug application for a diestrus female msP rat (inset). We found that in all groups, AM251 had no significant effect on EPSP amplitudes in Wistars {94.3 ± 3.1 and 94.0 ± 5.5 percent of baseline for male rats [t(8) = 1.85, n = 9 cells from six rats] and female rats [t(11) = 1.10, n = 12 cells from five rats], respectively} or msPs {82.7 ± 7.4 and 99.0 ± 4.0 percent of baseline for male rats [t(6) = 2.35, n = 7 cells from three rats] and female rats [t(18) = 0.24, n = 19 cells from 15 rats], respectively}, suggesting no tonic CB 1 signaling at glutamatergic synapses in the CeA (Fig. 5b) . Further analysis of female rats into sub-groups by estrous cycle (including cycle control female rats) did not reveal any significant effects of AM251 [Wistar: diestrus t(5) = 0.83, n = 6 cells from two rats; estrus t(5) = 0.68, n = 6 cells from three rats; msP: diestrus t(12) = 0.39, n = 13 cells from eight rats; estrus t(2) = 1.95, n = 3 cells from three rats; cycle control t(2) = 0.03, n = 3 cells from three rats] (Fig. 5c, d) .
Additionally, AM251 treatment resulted in no significant changes in PPR from baseline at interstimulus intervals of 50 milliseconds (141.7 ± 23.0 and 109.8 ± 6.0 percent male and female Wistar rats, 100.4 ± 10.4 and 100.0 ± 8.0 percent male and female msP rats, respectively) and 200 milliseconds (95.7 ± 9.0 and 113.2 ± 11.3 percent male and female Wistar rats, 103.5 ± 12.2 and 122.1 ± 12.3 percent male and female msP rats, respectively). A two-way ANOVA of strain and sex found a significant main effect of sex [F(1, 34) = 5.5, P < 0.05] at the 100-millisecond (99.2 ± 9.6 and 118.2 ± 7.7 percent male and female Wistar rats, 93.6 ± 6.3 and 109.6 ± 5.2 percent male and female msP rats, respectively) interstimulus interval with no effect of strain [F(1, 34) = 0.91] and no interaction effect [F(1, 34) = 0.04]; however, a Bonferroni post hoc test indicated no significant differences between individual groups.
CB 1 antagonism does not alter acute ethanol effects
Finally, we examined whether blockade of CB 1 receptors via AM251 interfered with the effects of acute ethanol. Therefore, in most of the cells where we applied AM251, we subsequently co-applied AM251 and 44 mM ethanol (Fig. 6 ). In all groups tested, combined application of ethanol and AM251 (subsequent to AM251 alone) did not alter the effects of acute ethanol alone seen for each group (Fig. 2a, b) . Subdividing female data into cycles (Fig. 6c, d ) did not reveal a change in the lack of interaction between AM251 and ethanol. The coapplication of ethanol and AM251 did not alter PPR from baseline at any of the interstimulus intervals tested (data not shown).
DISCUSSION
In this study, we have characterized CeA-stimulated glutamatergic transmission in a rat genetic model of high stress and anxiety (mimicking the alcohol-dependent phenotype) and its background strain; investigated modulation of this signaling by ethanol and cannabinoids; and found both sexually dimorphic and strain-specific effects of these drugs in modulating glutamatergic signaling. Because the CeA is heavily involved in both stress responses and the effects of alcohol drinking (Koob & Le Moal 2008; Koob & Volkow 2010) , understanding neuronal functioning in this area is key to understanding the interplay of stress and alcohol. As previous research has shown sexual dimorphism in the responses to both stress and alcohol (Chester et al. 2008; Logrip et al. 2016; Marco et al. 2017; Varlinskaya, Kim, & Spear 2017) , understanding differential CeA glutamatergic signaling and modulation between sexes is integral to developing treatments for these highly comorbid disorders.
We analyzed sex differences by first comparing male to female rats and then grouping female rats according to estrous cycle for further comparison. Because we did not select for cycle, the majority of female neurons we recorded from were from rats in diestrus or estrus at the time of sacrifice. The proestrus phase of the estrous cycle is only approximately 12 hours long, and we found few animals in this phase. As we were not able to record from enough CeA neurons in proestrus animals to represent each experimental condition, we could not include the proestrus data in this study. As diestrus is the phase consistent with the lowest levels of cycling hormones, we hypothesized that glutamatergic synaptic responses from diestrus animals would be most comparable with those from males, with synaptic responses from estrus animals more likely to differ. However, we found no differences in baseline CeA glutamatergic transmission between male and female rats of either msP or Wistar rats, regardless of estrous cycle. We found baseline strain differences, regardless of sex, in PPR at the 50-millisecond interstimulus interval, with PPR generally higher in msPs than in Wistars, which suggests one of a few possible changes in presynaptic calcium functioning in msP terminals at the second stimulation. One is that the calcium influx from the first stimulation is high enough to saturate calcium buffer proteins, resulting in higher levels of calcium during the second stimulation. Another is that calcium influx is greater for the second stimulation owing to modulation of calcium channels. The last is that there are separate release mechanisms that respond to the initial high level of calcium influx or to the sustained residual calcium after the first stimulation. Interestingly, synaptotagmin 7 has recently been implicated as a low-affinity calcium sensor responsible for short-term facilitation at glutamatergic synapses (Jackman et al. 2016) . Which of these mechanisms might be responsible for the increased facilitation seen in the msPs warrants further investigation.
Here we recapitulated the ethanol-induced decrease in evoked CeA EPSP amplitudes as previously reported in male msP and Wistar rats, with no change in PPR, indicating a lack of presynaptic site for the actions of ethanol (Herman et al. 2016) . However, we find a strain-specific sex difference in the effects of ethanol as female Wistar EPSPs have the same effect as the male rats, while female msP EPSPs are unaffected by ethanol. Considering estrous cycle for the female rats, the diestrus msPs are unaffected by ethanol, while the effects of ethanol on estrus female Wistar and msP rats are less straightforward. In general, estrus female rats showed a greater (although non-significant) effect of ethanol than diestrus female rats, suggesting an interaction with some component of estrogen signaling. Estrogen receptor immunoreactivity is present in the amygdala (Mitra et al. 2003) , and many amygdala neurons have coexpression of estrogen receptors and NMDA receptors (Kia et al. 2002) , suggesting that glutamatergic signaling in the CeA may be susceptible to estrous cycle-dependent reorganization. This also suggests that the lack of estrogen signaling in diestrus female msP rats likely interacts with heightened stress system signaling seen in the msPs to block ethanol's effects, although it is not clear how this occurs, but further investigation of these interactions is warranted.
Cannabinoid receptor type 1 activation has been shown to decrease glutamate release in many brain areas, including the CeA, of male rodents (Gerdeman & Lovinger 2001; Ramikie et al. 2014) . However, to our knowledge, this is the first study to investigate CB 1 receptor function on CeA glutamatergic signaling in both female and male rodents. Generally, CB 1 agonists are thought to decrease anxiety-like behavior, while disruptions in CB 1 signaling are anxiogenic. A disruption in CB 1 signaling in the msPs might then explain their high stress and anxiety phenotype via decreased receptor expression or function, or decreased eCB signaling. However, here we find that Win decreased EPSP amplitudes in both male and female msPs, suggesting expression of functional CB 1 receptors in CeA. Additionally, we find no effects of the CB 1 -specific antagonist AM251, suggesting no tonic CB 1 signaling at glutamatergic synapses of msPs or Wistars. Thus, it is possible that the msPs express greater numbers of CB 1 receptors in CeA, leading to the enhanced effect of Win in these animals. Interestingly, in Wistars, Win had sexually dimorphic effects, modestly decreasing EPSP amplitudes in male but having no effect in female rats. This lack of effect with Win was consistent in both diestrus and estrus animals, indicating that this irregular result is not likely dependent on estrogen signaling.
The enhanced Win effect seen in msPs may in fact be directly connected with enhanced glutamatergic activity. CeA glutamate neurons in Wistars may be under tighter regulatory control of glutamate release, thus diminishing further inhibition by Win. Metabotropic glutamate receptors from the group 2 family (mGluR 2 ) have previously been shown to block effects of CB 1 signaling by competing at downstream activators (Xi et al. 2006) , in this case already acting through G i /G o proteins to inhibit neurotransmitter release via inhibition of cAMPdependent signaling. Wistar rats from the Charles River line fully express mGluR 2 , and although expression levels of mGluR 2 is unknown for msP rats, msPs were bred from Sardinian-preferring rats that have been found to have a lower expression of mGluR 2 (Wood et al. 2016 ). Thus, it is possible that lowered expression of mGluR 2 in msPs results in increased cAMP-dependent PKA signaling, which downstream leads to increased calcium causing enhanced glutamatergic signaling. This system would be very susceptible to the effects of Win in activating G i /G o proteins to inhibit cAMP production. Thus, future experiments will need to examine possible interactions between the CB 1 and mGluR 2 /PKA systems in the msP rats.
We find that for male msP and Wistar rats, the combined effects of Win and ethanol have a somewhat additive effect. Despite the diminished effects of Win in the subset of cells that also received ethanol for male Wistar rats, in both male Wistar and msP rats, the added ethanol further inhibited EPSPs beyond the magnitude seen with ethanol or Win alone, indicating that the method of inhibition on glutamatergic signaling is distinct for each drug. However, for female rats, we find specific effects of Win-dependent and ethanol-dependent on strain. In female Wistar rats, Win blocks the inhibitory effects of ethanol, while in female msP rats, Win induces an inhibitory effect of ethanol that was not present for ethanol alone. For female Wistar rats, this suggests that ethanol acts through a shared mechanism on a coincident downstream target, so the effect is occluded by the pre-applied Win. For female msP rats, these data suggest that CB 1 receptor activation of a downstream signaling cascade may be priming the effects of ethanol. Although unlikely, in both cases, we cannot rule out the possibility that ethanol directly acts on CB 1 receptors. Notably, these mechanisms would then be sexually dimorphic and strain specific. Examination of estrous cycle in these effects is not more informative. In Wistars, both diestrus and estrus female rats exhibit the block of ethanol effects. In msPs, diestrus female rats exhibit the induced ethanol effect, while estrus female rats have a diminished ethanol effect on top of the Win. This would suggest that estrogens may prevent the Win-induced ethanol effect in CeA of female msP rats. Further investigation of these interactions is warranted.
In summary, we have found sex-specific and strainspecific effects of ethanol, sex-specific and strain-specific effects of the CB 1 agonist Win, sex-strain-specific combined effects of Win and ethanol, and no interaction between CB 1 antagonism via AM251 and the effects of acute ethanol in CeA. The msP rat line is suggestive of effects likely to be seen in chronic ethanol-exposed animals, and because we found specific effects in both this line and the background naïve Wistar strain, it is likely that the transition to alcohol dependence occurs in a sexually dimorphic manner. In fact, many effects of ethanol and stress occur in a sexually dimorphic manner (Morales, McGinnis, & McCool 2015; Retson et al. 2015; Bekhbat et al. 2016; Logrip et al. 2016) , and these differential effects must be considered in the pursuit of treatments for alcohol and stress disorders, like alcohol dependence.
